Literature DB >> 11190063

Peptic ulcer and Helicobacter pylori.

H Cohen1.   

Abstract

Although there has been an explosion of data not only since the discovery of H. pylori in 1982, but also since the first comprehensive review of H. pylori in the Gastroenterology Clinics in 1993, much remains to be learned. In 1993, there were many skeptics doubting the importance of H. pylori in ulcer disease. Although this skepticism has dissipated, many ulcer patients infected with H. pylori still do not receive appropriate therapy. This situation possibly relates to the safety, efficacy, and simplicity of prescribing acid-suppressive therapy in contrast to the confusion regarding anti-H. pylori treatment regimens. Among the many continuing unanswered questions regarding the role of H. pylori and PUD are the still enigmatic nature of host, environmental, and H. pylori-related factors that determine outcome. Why do only some infected individuals (and why do more men than women) develop PUD, and what determines whether gastric ulcers or duodenal ulcers develop? What is the explanation for the seasonal variation in ulcer disease? Although PUD is an infectious disease, are other environmental factors critical for the manifestation of ulcers in association with infection? What factors govern the outcome of the combination of H. pylori infection and NSAID use? Has attention been too focused first on the pathophysiology of acid secretion and now on H. pylori? In curing H. pylori in association with PUD, are clinicians going to displace disease northward, substituting erosions, inflammation, and neoplasia (and associated symptoms) in the esophagus and gastroesophageal junction for an ulcer crater (and its associated symptoms) in the duodenum or stomach? The epidemiology of PUD is changing--in more recent reports of ulcer patients, H. pylori and NSAID use are less prevalent than in earlier reports. These questions and comments should not be misinterpreted as advocating a lack of aggressiveness in diagnosis and treatment of H. pylori in the setting of PUD, however. Nevertheless, the pendulum is swinging.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11190063     DOI: 10.1016/s0889-8553(05)70146-1

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  11 in total

1.  Risk of oesophageal cancer by histology among patients hospitalised for gastroduodenal ulcers.

Authors:  Shahram Bahmanyar; Kazem Zendehdel; Olof Nyrén; Weimin Ye
Journal:  Gut       Date:  2006-09-27       Impact factor: 23.059

2.  Helicobacter pylori seroprevalence in patients with lung cancer.

Authors:  Nikiphoros Philippou; Panagiotis Koursarakos; Evgenia Anastasakou; Vasiliki Krietsepi; Stavroula Mavrea; Anastasios Roussos; Dionissia Alepopoulou; Irineos Iliopoulos
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 3.  Clinical pharmacology of proton pump inhibitors: what the practising physician needs to know.

Authors:  Malcolm Robinson; John Horn
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 4.  Causal role of Helicobacter pylori infection in gastric cancer.

Authors:  Takafumi Ando; Yasuyuki Goto; Osamu Maeda; Osamu Watanabe; Kazuhiro Ishiguro; Hidemi Goto
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

Review 5.  Helicobacter pylori infection and respiratory diseases: a review.

Authors:  Anastasios Roussos; Nikiforos Philippou; Konstantinos I Gourgoulianis
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

6.  Helicobacter pylori infection and pediatric asthma.

Authors:  Abdullah Karimi; Koroush Fakhimi-Derakhshan; Farid Imanzadeh; Mohamad Rezaei; Zahra Cavoshzadeh; Saeid Maham
Journal:  Iran J Microbiol       Date:  2013-06

7.  Evaluation of the Correlation Between Childhood Asthma and Helicobacter pylori in Kashan.

Authors:  Tahere Khamechian; Amir Hossein Movahedian; Ghasem Ebrahimi Eskandari; Marzieh Heidarzadeh Arani; Abouzar Mohammadi
Journal:  Jundishapur J Microbiol       Date:  2015-06-01       Impact factor: 0.747

8.  Detection of helicobacter pylori in bronchoalveolar lavage of patients with chronic obstructive pulmonary disease by real time polymerase chain reaction.

Authors:  Mitra Samareh Fekri; Seyed Mehdi Hashemi Bajgani; Atefe Rasti; Rostam Yazdani; Hamid Reza Mollaie
Journal:  Jundishapur J Microbiol       Date:  2014-12-07       Impact factor: 0.747

9.  Association between helicobacter pylori infection and primary open angle glaucoma.

Authors:  V Samarai; N Sharifi; Sh Nateghi
Journal:  Glob J Health Sci       Date:  2014-09-18

10.  Helicobacter pylori in patients suffering from pulmonary disease.

Authors:  Narges-Ol-Sadat Shams-Hosseini; Seyed Ali Javad Mousavi; Maryam Kadivar; Ehsan Ahmadipour; Rostam Yazdani; Vahan Moradians
Journal:  Tanaffos       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.